The New York Times Features Dr. High and her Novel Genome-Editing Technique
A cut here, a paste there and genetics researchers have cured hemophilia—at least in theory, and only in mice, but a new technique shows much promise for treating this and other genetic diseases. Dr. Katherine High, a gene therapy expert at The Children’s Hospital of Philadelphia, was the lead researcher in this novel genome-editing study. As the science advances, Dr. High emphasizes that safely developing a novel disease treatment can’t be rushed: “This may well revolutionize the field, but it won’t do so overnight,” said Dr. High in a recent New York Times article. Read the article to learn more about the work on hemophilia in animal models, and then to learn more about Dr. High and her continued work in genetic research.